ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

NCI RFAs Available

May 5, 2000

Young Early-Stage Patients Can Preserve Fertility

August 28, 2009

In Brief: Judith Salerno Named President and CEO of Komen

June 21, 2013

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005